44.06

0.02% -0.010

Livanova Plc (LIVN)

Overview News Price History Option Chain Financials Discussions Forecast

Livanova Plc stock is traded at $44.06, with a volume of 1.06M. It is down -0.02% in the last 24 hours and up +23.35% over the past month. UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Previous Close:

$44.07

Open:

$44.07

24h Volume:

1.06M

Relative Volume:

1.32

Market Cap:

$2.01B

Revenue:

$1.24B

Net Income/Loss:

$23.68M

P/E Ratio:

104.90

EPS:

0.42

Net Cash Flow:

$108.67M

1W Performance:

+19.79%

1M Performance:

+23.35%

6M Performance:

-14.66%

1Y Performance:

-28.88%

1-Day Range:

$43.88

$44.98

1-Week Range:

$35.00

$44.98

52-Week Range:

$32.48

$63.57

Livanova Plc Stock (LIVN) Company Profile

Name

Livanova Plc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

4402033250662

Address

20 EASTBOURNE TERRACE, LONDON

Employee

2,900

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LIVN's Discussions on Twitter

Compare LIVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIVN Livanova Plc	44.06	2.01B	1.24B	23.68M	108.67M	0.42
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Livanova Plc Stock (LIVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Oct-04-24	Initiated	Goldman	Buy
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy
Sep-06-23	Initiated	HSBC Securities	Hold
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-14-23	Initiated	Mizuho	Neutral
Dec-21-22	Initiated	Barclays	Equal Weight
Apr-06-22	Initiated	Wolfe Research	Outperform
Feb-24-22	Upgrade	UBS	Neutral → Buy
Dec-03-21	Initiated	Goldman	Buy
Aug-20-21	Reiterated	Needham	Buy
Jul-20-21	Upgrade	Needham	Hold → Buy
Mar-03-21	Downgrade	Berenberg	Buy → Hold
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform
Jun-26-20	Reiterated	Needham	Buy
Oct-30-19	Reiterated	Needham	Buy
Feb-28-19	Reiterated	Needham	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-02-18	Reiterated	Needham	Buy
Jun-08-18	Initiated	Stifel	Buy
May-31-18	Reiterated	Needham	Buy
Feb-28-18	Reiterated	Needham	Buy

View All

Livanova Plc Stock (LIVN) Latest News

May 09, 2025

Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com

May 09, 2025

May 08, 2025

Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia

May 08, 2025

LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus

May 08, 2025

LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer

May 08, 2025

Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus

May 08, 2025